BEVACIZUMAB for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,810 adverse event reports in the FDA FAERS database where BEVACIZUMAB was used for Lung neoplasm malignant.
Most Reported Side Effects for BEVACIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 12,094 | 15.5% | 3,560 | 1,814 |
| Death | 8,493 | 10.9% | 8,485 | 726 |
| Diarrhoea | 4,911 | 6.3% | 1,110 | 1,932 |
| Disease progression | 4,653 | 6.0% | 1,838 | 749 |
| Fatigue | 4,572 | 5.9% | 1,358 | 1,294 |
| Nausea | 4,357 | 5.6% | 1,050 | 1,459 |
| Hypertension | 4,309 | 5.5% | 534 | 1,181 |
| Anaemia | 3,221 | 4.1% | 587 | 1,289 |
| Vomiting | 3,193 | 4.1% | 794 | 1,404 |
| Neutropenia | 2,875 | 3.7% | 449 | 720 |
| Pyrexia | 2,602 | 3.3% | 512 | 1,618 |
| Decreased appetite | 2,559 | 3.3% | 682 | 944 |
| Asthenia | 2,489 | 3.2% | 790 | 924 |
| Drug ineffective | 2,488 | 3.2% | 493 | 369 |
| Proteinuria | 2,384 | 3.1% | 325 | 459 |
Other Indications for BEVACIZUMAB
Product used for unknown indication (9,041)
Hepatocellular carcinoma (7,773)
Colorectal cancer metastatic (5,474)
Ovarian cancer (5,283)
Non-small cell lung cancer (4,136)
Colon cancer (4,015)
Colorectal cancer (2,788)
Breast cancer (2,130)
Glioblastoma (1,610)
Rectal cancer (1,546)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
PACLITAXEL (1,747)
ATEZOLIZUMAB (1,262)